The Hematology Division of the Agostino Gemelli IRCCS University Polyclinic Foundation is an integral part of the Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, and also belongs to the Institute of Hematology of the Catholic University of the Sacred Heart.
The Hematology Division has been active for over 30 years.
It was completely renovated in 2003; it offers 29 beds with a protective isolation area that consists of 8 beds for intensive hematological therapy and stem cell transplantation with 2 sterile rooms mainly dedicated to transplants from a voluntary donor.
They guarantee patients, in particular clinical conditions or undergoing specific therapeutic programs, a high hygienic standard. Within this division operate the UOSA of Therapy of Acute Hemopathies directed by Prof.ssa Simona Sica and the UOSA of Geriatric Hematology and Rare Hemopathies directed by Prof. Livio Pagano.
On average, over 1,000 hospitalizations are carried out in a year with an average stay of about 10 days.
The diagnosis and/or treatment of non-Hodgkin's lymphomas is the most frequent reason for hospitalization, followed by the diagnosis and/or treatment of acute myeloid and lymphoid leukemias.
are some of the other major diseases treated at the Division.
The Hematology Division is located on the 5th floor of Wing E of the hospital.
National, European and international clinical studies and experimental protocols are underway for the treatment of acute hemopathies, guaranteeing cutting-edge therapies in compliance with current legislation and in compliance with the professional ethics of our institution.
The Unit of Geriatric Hematology and Rare Hemopathies is involved in the diagnosis and treatment of the main malignant hemopathies that typically arise in elderly subjects such as:
All the most current therapeutic aids are used with the availability of the most modern drugs both in controlled clinical trials and in daily clinical practice.
Particular attention is paid to the forms of MDS / LMA secondary to other neoplasia in which we have more than 20 years of experience.
Rare hemopathies are also included in the area of expertise. Institutional and regional pathways have been activated for the diagnosis and treatment of Systemic Mastocytosis, Malignant Histiocytosis and Thrombotic Thrombocytopenic Purpura.
The doctors of the unit also have experience and expertise in the treatment of Dendritic-Plasmocytoid Neoplasms (BPDCN), T-NK Lymphomas and in the diagnosis and treatment of Hairy Cell Leukemia.
The Transplant Center is accredited according to the current Italian regulations and according to the JACIE criteria (joint accreditation Committee-ISCT (Europe) & EBMT).
The JACIE (Joint Accreditation Committee of ISCT and EBMT) Standards are designed to promote quality in the field of clinical and laboratory activity, applied to the transplantation of hematopoietic stem cells and progenitors, creating a standardized accreditation system, officially recognized throughout Europe. Therefore, JACIE accreditation represents the means by which a center can demonstrate that it carries out its business at a level of competence in compliance with recognized standards of excellence.
The transplant program has been active at Gemelli since 1988 and has been accredited for all types of hematopoietic stem cell transplants, from the simplest, autologous transplant (the patient receives, after a high-dose chemotherapy, his own cells that have been taken from the bone marrow and then temporarily cryopreserved) to the more complex one, allogeneic transplantation from an unfamiliar donor that can be performed with hematopoietic stem cells taken from bone marrow or peripheral blood through apheresis or from cryopreserved umbilical cord blood and more recently with partially compatible or haploidentical transplantation.
To date, more than 1,600 transplants have been performed at the Division of Hematology.
The new department located on the 1st floor of wing E of our Polyclinic, inaugurated in December 2017, is added to the Department located on the 5th floor, wing E and is equipped with 14 controlled sterility rooms and responds to the growing demand for haematological patients waiting of transplantation and cell therapy.
